MIRA INFORM REPORT

 

 

1Report Date :

14.09.2012

 

IDENTIFICATION DETAILS

 

Name :

LEBEN LABORATORIES PRIVATE LIMITED

 

 

Registered Office :

L-4 MIDC, Phase III, Akola-444104, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

02.08.1988

 

 

Com. Reg. No.:

11-48316

 

 

Capital Investment/ Paid-up Capital:

Rs.6.000 Million

 

 

CIN No.:

[Company Identification No.]

U24230MH1988PTC048316

 

 

IEC No.:

0396056695

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUML0440C

 

 

PAN No.:

[Permanent Account No.]

AAACL2524M

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceutical Formulations

 

 

No. of Employees:

Approximately 240 (Office 81, Factory 159)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (51)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 577000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well-established and reputed company having good track. Financially company is performing well. Trade relations are reported to be fair. Business is active. Payment are reported to be regular and as per commitment. 

 

The company can be considered for normal business dealings at usual trade terms and conditions. 

 

 

NOTES:

 

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office/Factory :

L-4 MIDC, Phase III, Akola-444104, Maharashtra, India

Tel. No.:

91-724-2258393 / 648/ 2258328

Fax No.:

91-724-2258371

E-Mail :

companyclent007@gmail.com

akl_leben2@dataone.in

akl_leben1@sancharnet.in

Website :

http://www.lebenlab.com

Area :

59998 Sq.ft.

Location :

Owned

 

 

Head Office :

11, Mahavir Mansion. 70, Trinity Street, Near Metro Cinema, Mumbai – 400002, Maharashtra, India

Tel. No.:

91-22-22075301

Fax No.:

91-22-22075303

 

 

DIRECTORS

 

As on 30.09.2011

 

Name :

Mr. Bharat Nitilal Shah

Designation :

Chairman and Managing Director

Address :

Block No. 5, Kamal Housing Society Opposite Main Hospital, Akola-444001, Maharashtra, India

Date of Birth/Age :

01.10.1957

Qualification :

Master of Pharmacy Diploma in Business Management

Date of Appointment :

02.08.1988

Din No.:

00778304

 

 

Name :

Mr. Haresh Nitilal Shah

Designation :

Whole Time Director

Address :

Prachi, Plot No. 6, Radhe Nagar, Beside Collector Office, Akola-444001, Maharashtra, India

Date of Birth/Age :

19.12.1959

Qualification :

Bachelor of Commerce

Date of Appointment :

02.08.1988

Din No.:

00778264

 

 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2011

 

Names of Shareholders

 

No. of Shares

Bharat Nitilal Shah

 

60

Haresh Nitiala Shah

 

60

Bharat Nitilal Shash Jointly with Neeta Bharat Shah

 

17940

Haresh Nitilal Shah Jointly with Neeru Haresh Shah

 

17940

Neeta Bharat Shah Jointly with Bharat Nitilal Shah

 

2400

Parth Bharat Shah

 

3000

Bharat Nitilal Shah (HUF)

 

600

Neeru Haresh Shah Jointly with Haresh Nitilal Shah

 

2400

Haresh Nitialal Shah (HUF)

 

600

Indumati Nitilal Shah Jointly with Bharat Nitilal Shah

 

6000

Indumati Nitilal Shah Jointly with Haresh Nitilal Shah

 

6000

Manan Haresh Shah

 

3000

Total

 

60000

 

 

As on 30.09.2011

 

Category

 

Percentage

 

 

 

Directors or relatives of directors

 

100.00

 

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceutical Formulations

 

 

 

 

PRODUCTION STATUS As on 31.03.2011

 

Particulars

Unit

Installed Capacity

General Tablet

Lacs Tablets

3750.000

Liquid Oral

Lacs Ltrs

9.00

Ointment

 

 

External Preparation

Lacs Kgs.

1.50

Lotion

Lacs Ltrs

1.50

Capsule

 

 

General Capsule

Lacs Capsules

600.00

Oral Powder

Lacs Kgs.

0.60

B- Lactum

 

 

Tablets

Lacs Tablets

600.00

Capsule

Lacs Capsules

600.00

Dry Syp

Lacs Bottles

30.00

 

 

GENERAL INFORMATION

 

Suppliers:

  • Alka Laboratories Private Limited
  • Alpha Pharma Daman Private Limited
  • ARIL Pharmaceuticals
  • Ashi Enterprises
  • Akshat Chemicals
  • ACE Pharama
  • ABIl Chem pharama Private Limited
  • Ag Tech Solutions
  • Chirag Industries
  • City Land Express
  • Chemical (India) Company
  • Bilcare Limited
  • B. Pankaj and Company  
  • Bharat Rubber Works
  • Ashok Traders

 

 

Customers :

MAJOR CUSTOMERS NAMES

 

Domestic:

 

·         Agrawal Drug Corporation

·         Anu Drug Dist

·         Baba Drug House

·         Banke Bihari Medical Store

·         Bhavana Enterprises

·         Durgasons Pharmco

·         G.C. Drug

·         India Drug House Agency

·         Ishi Pharmaceuticals

·         Karunamoyee Enterprises

·         Kumar Corporation

·         Lotus Pharma

·         M.S. Drugs and Pharmaceutical

 

Overseas:

 

·         A.D.K. Company Private Limited

·         Andyco Pharmacy

·         Cure Pharma Limited

·         Dat Internatonal

·         Medicaments Pharma Private Limited

·         Nawakrama Private Limited

·         Pharma Plus Limited

·         Pharmavet Limited

·         Salpa Biotech Private Limited

·         State Pharmaceutical Corporation

·         Tejay Pharmaceuticals Limited

·         Unisel Pharma (Kenya) Limited

 

 

No. of Employees :

Approximately 240 (Office 81, Factory 159)

 

 

Bankers :

·         Corporation Bank, through Mumbai Branch, Abdul Rehman Street, Mumbai – 400003, Maharashtra, India 

·         The Akola Janta Commercial Co-Operative Bank

 

 

Facilities :

Rs. In Millions

Secured Loans

As on 31.03.2011

Rs. in millions

As on 31.03.2010

Rs. in millions

Corporation Bank, PCL Loan A/c

16.412

0.000

Corporation Bank, Mumbai , C.C A/c

16.488

0.000

Akola Janta Bank, Mumbai (Current A/c)

0.003

0.000

HDFC Bank Limited, Akola (Current A/c)

0.111

0.000

Total

33.014

 0.000

 

Unsecured Loans

As on 31.03.2011

Rs. in millions

As on 31.03.2010

Rs. in millions

Directors

16.520

14.268

Shareholders

45.149

39.511

Total

61.669

53.779

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

M G Chawre and Company

Chartered Accountant

Address :

Wakhre Complex, Jather Peth, Akola-444005, Maharashtra, India

Tel. No.:

91-724-2450324

E-Mail :

chawaremg@rediffmail.com

 

 

Associates :

Elemco

 

 

CAPITAL STRUCTURE

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

200000

Equity Shares

Rs. 100/- each

Rs. 20.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

60000

Equity Shares

Rs. 100/- each

Rs. 6.000 Millions

 

 

 

 

 

 

Note: 50.000 Equity shares of Rs.100/- each issues as Bonus shares 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

6.000

6.000

6.000

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

138.133

108.751

89.919

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

144.133

114.751

95.919

LOAN FUNDS

 

 

 

1] Secured Loans

33.014

0.000

12.728

2] Unsecured Loans

61.669

53.779

40.522

TOTAL BORROWING

94.683

53.779

53.25

DEFERRED TAX LIABILITIES

3.355

3.351

3.577

 

 

 

 

TOTAL

242.171

177.881

152.746

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

87.758

63.225

62.646

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.125

0.126

0.126

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

95.041
67.327

51.950

 

Sundry Debtors

104.237
70.771

71.576

 

Cash & Bank Balances

2.725
5.148

2.511

 

Other Current Assets

0.000
0.000

0.000

 

Loans & Advances

56.874
35.376

25.300

Total Current Assets

258.877

178.622

151.337

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

69.246
40.836

38.832

 

Other Current Liabilities

31.647
20.342

20.015

 

Provisions

3.696
2.914

2.516

Total Current Liabilities

104.589

64.092

61.363

Net Current Assets

154.288

114.530

89.974

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

242.171

177.881

152.746

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

 

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

 

408.404

318.653

 

 

Other Income

 

6.840

6.650

 

 

TOTAL                                     (A)

498.918

415.244

325.303

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Material Consumed

 

203..655

140.605

 

 

Salary and Remuneration

 

25.965

22.731

 

 

Manufacturing and Other Expenses

 

30.648

29.951

 

 

Packing Material Consumed

 

57.875

44.668

 

 

Selling and Distribution Expenses

 

44.485

39.775

 

 

Other Administrative Expenses

 

14.233

9.911

 

 

Loss of Sale of Fixed Assets

 

0.020

0.000

 

 

Bad Debts

 

0.036

0.135

 

 

Increase/ Decrease in Stock

 

[6.844]

2.579

 

 

TOTAL                                     (B)

459.281

370.073

290.355

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

Including Interest and Deprecation Expense 

45.171

34.948

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

5.433

5.307

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

39.738

29.641

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

8.533

9.535

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

39.637

31.205

20.106

 

 

 

 

 

Less

TAX                                                                  (I)

10.255

12.373

6.536

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

29.382

18.832

13.570

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

107.011

88.179

74.609

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

136.393

107.011

88.179

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

230.138

166.302

148.489

 

TOTAL EARNINGS

 

166.302

148.489

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Traveling

NA

0.386

0.265

 

 

Capital Goods

NA

1.299

1.807

 

 

Others

NA

6.751

2.429

 

TOTAL IMPORTS

NA

8.436

4.501

 

 

 

 

 

 

Earnings Per Share (Rs.)

-

313.87

--

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

5.89

4.54

4.17

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

NA

7.64

6.31

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

11.43

12.90

9.40

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.28

0.27

0.21

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.38

1.03

1.19

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.48

2.79

2.47

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Check List by Info Agents

Available in Report [Yes/No]

Year of Establishment

Yes

Locality of the Firm

Yes

Constitution of the firm

Yes

Premises details

Yes

Type of Business

Yes

Line of Business

Yes

Promoters background

Yes

No. of Employees

Yes

Name of Person Contacted

No

Designation of contact person

No

Turnover of firm for last three years

Yes

Profitability for last three years

Yes

Reasons for variation <> 20%

-

Estimation for coming financial year

No

Capital the business

Yes

Details of sister concerns

Yes

Major Suppliers

Yes

Major Customers

Yes

Payment Terms

No

Export / Import Details [If Applicable]

Yes

Market Information

-

Litigations that the firm / promoter involved in

-

Banking Details

Yes

Banking Facility Details

Yes

Conduct of the banking account

-

Buyer visit details

-

Financials, if provided

Yes

Incorporation details, if applicable

Yes

Last accounts filed at ROC

Yes

Major Shareholders, if applicable

Yes

Date of Birth of Proprietor/Partner/Director, if available

Yes

PAN of Proprietor/Partner/Director, if available

No

Voter ID No of Proprietor/Partner/Director, if available

No

External Agency Rating, if available

No

 

 

NOTE:

 

The Registered office of the company has been shifted from 11, Mahavir Mansion. 70, Trinity Street, Near Metro Cinema, Mumbai – 400002, Maharashtra, India to the present address (w.e.f.05.03.2008)

 

FORM 8

 

Corporate identity number of the company

U24230MH1988PTC048316

Name of the company

LEBEN LABORATORIES PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

L-4 MIDC, Phase III, Akola-444104, Maharashtra, India

Email: companyclient007@gmail.com

This form is for

Modification of charge

Charge identification (ID) number of the charge to be modified

90214099

Type of charge

·         Immovable property

·         Any interest in immovable property

·         Book debts

·         Movable property (not being pledge)

·         Floating charge

·         Others

Particular of charge holder

Corporation Bank, through Mumbai Branch, Abdul Rehman Street, Mumbai – 400003, Maharashtra, India  

Email: akl_leben2@dataone.in

Nature of instrument creating charge

1. Export Credit Agreement for Pre-Shipment in Foreign Currency.

2. Memorandum of Deposit of Title Deeds.

3. Counter Guarantee for Opening Irrevocable Foreign Documentary Credit/Standby Letter of Credit.

4. For Inland/Foreign Bill.

5. For Foreign Bills.

6. Counter Guarantee for the Bank Guarantee/s Issued by the bank.

7. Undertaking Letter.

8. Export Credit Agreement.

9. Supplemental Common Deed of Hypothecation of Movables/Assets/Debts.

Date of instrument Creating the charge

05.01.2012

Amount secured by the charge

Rs. 35.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of interest:

1. For PCL upto 180 days not excee. 350 basis points over LIBOR and beyond 180 days and upto 360 rate as above+200 basis 2. For bank gurantee: 5.85% over and above base rate i.e effective rate 16.50%

 

Extent and operation of the charge

The charge extend to principle, interest, service charge, commitment charges, commission, discount, custom duty, penalty, demurrage charge, storage charge, clearing and forwarding charges, or for cost,

charges and expenses or all other monies payable and operate on all properties mentioned in the loan agreement.

 

Others:

Total loan limit is Rs. 35.000 Millions including Rs. 29.700 Millions as packing credit limit/ FDBN/FDBP/FDBD/PCFC/PSCFC, Rs. 3.000 Millions as cash credit limit and Rs. 5.000 Millions as Import/inland LC/BG

Short particulars of the property charged (Including location of the property)

All that piece and parcel of leasehold Industrial Property admn. 3960 Sq.Mt Plot No L-4, Phase III MIDC, Village Shivar, Taluka and Dist Akola Maharashtra along with building and machinery lying therein

 

All the present and future stock of goods consisiting of drugs, chemicals, pharmaceuticals, medicine etc, plant and machiny, furniture and fixtures, book debts, receivables (present and future) as located above (i) or any other premises whever else or in course of transit or delivery to the borrower

Particulars of the present modification

By the present modification the total limit of Rs. 22.500 Millions is enhanced to Rs. 35.000 Millions  including:

Cash credit                                               :   0.300 Millions

PCL/FDBN/FDBP/FDBD/PCFC/PSCFC  : 29.700 Millions

Import/ Inland LC cum BG                        : 5.000  Millions

and the charge to that extent is enhanced on the properties mentioned in loan agreement.

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.55.54

UK Pound

1

Rs.89.31

Euro

1

Rs.71.62

 

 

INFORMATION DETAILS

 

 

Report Prepared by :

BYI

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

6

--RESERVES

1~10

6

--CREDIT LINES

1~10

6

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

YES

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

51

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.